Trial intelligence / Profile preview

Taurine as an Add-on for Bipolar Disorder

NCT00217165Phase 2Completed

Sponsor
McLean Hospital
Start
Apr 2005
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of taurine in bipolar disorder (BD), sponsored by McLean Hospital. Started Apr 2005; status: completed.

02

Drugs

taurine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00217165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00217165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call